$AFJK

Aimei Health Technology Co., Ltd. (AFJK) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Extension of the Termination Date An aggregate of $34,330.96 (the “ Extension Payment ”) has been deposited into the trust account of Aimei Health Technolo

Aimei Health Technology Co., Ltd. (AFJK) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Extension of the Termination Date An aggregate of $34,330.96 (the “ Extension Payment ”) has been deposited into the trust account of Aimei Health Technolo

Aimei Health Technology Co., Ltd. (NASDAQ: AFJK, AFJKU, AFJKR) said it terminated its June 19, 2024 business combination agreement, as amended, with United Hydrogen Group Inc. The company delivered a termination notice on July 7, 2026, effective immediately, citing the outside date passing without closing.

Aimei Health Technology Co., Ltd. (AFJK) filed an SEC Form 8-K — Termination of a Material Definitive Agreement. false 0001979005 00-0000000 0001979005 2026-07-07 2026-07-07 0001979005 AFJK:OrdinarySharesParValue0.0001PerShareMember 2026-07-07 2026-07-07 0001979005 AFJK:RightsExchangeableIntoOnefifthOfOneOrdinaryShareMember 2026-07-07 2026-07-07 0001979005 AFJK:UnitsEachConsistingOfOneOrdin

Aimei Health Technology Co., Ltd. (AFJK) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. false 0001979005 0001979005 2026-07-06 2026-07-06 0001979005 AFJK:OrdinarySharesParValue0.0001PerShareMember 2026-07-06 2026-07-06 0001979005 AFJK:RightsExchangeableIntoOnefifthOfOneOrdinaryShareMember 2026-07-06 2026-07-06 0001979005 AFJK:UnitsEachConsistingOfOneOrdinaryShareAnd

Aimei Health Technology Co., Ltd. (AFJK) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001979005 0001979005 2026-06-24 2026-06-24 0001979005 AFJK:OrdinarySharesParValue0.0001PerShareMember 2026-06-24 2026-06-24 0001979005 AFJK:RightsExchangeableIntoOnefifthOfOneOrdinaryShareMember 2026-06-24 2026-06-24 0001979005 AFJK:UnitsEachConsistingOfOneOrdinaryShareAnd

Aimei Health Technology (NASDAQ:AFJK) saw short interest fall in May: 2,710 shares as of May 15, down 52.3% from 5,686 on April 30. Short interest was about 0.1% of shares, with a 1.3-day days-to-cover based on average volume. Weiss Ratings reiterated a “sell (d+)” rating. The stock traded near $42.09; it reported $0.02 EPS on May 4.

Aimei Health Technology (AFJK) has received a notice from Nasdaq regarding non-compliance with listing rules due to a delayed quarterly report on Form 10-Q for the period ended March 31, 2026. The company is actively working to complete and file the report and expects to regain compliance within the specified timeframe, noting that the notice has no immediate impact on its stock listing or trading.

Aimei Health Technology Co., Ltd (AFJK) has extended the deadline for its initial business combination from December 6, 2025, to January 6, 2026. This thirteenth extension was secured by a $34,330.96 payment into its trust account. An unsecured promissory note, convertible into private units, was issued to its sponsor and United Hydrogen Group Inc. to fund the extension.

NEW YORK, July 02, 2025 ( GLOBE NEWSWIRE ) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC ( the "M&A Class Action Firm" ) , has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.